There's currently no cure for dementia. Although some recently developed drugs show promise in slowing the progress of the ...

Could the bacteria in your mouth predict whether you are at risk of dementia? Emerging research suggests that the bacteria living on your tongue and gums may affect how the brain works and how it ...

Alzheimer’s is a mind-body malaise that experts say can take up to 20 years to run its fearsome course—like having a sliver ...

The FDA has approved the sBLA for once every 4 weeks lecanemab-irmb (Leqembi®) intravenous maintenance dosing.

Bacteria can also break down nitrite to produce nitric oxide, which improves circulation, including blood flow to the brain. This suggests that eating lots of nitrate-rich vegetables, such as leafy ...

II-73, has the potential to restore memory and cognitive function in a mouse model of Alzheimer's disease. The study demonstrates that the drug improves memory deficits and reverses brain cell damage, ...

A paradigm-shifting study from the Centre for Addiction and Mental Health (CAMH) shows an experimental drug, GL-II-73, has the potential to restore memory and cognitive function in a mouse model of ...

Scientists provide new evidence that preventing brain inflammation is a promising approach for the treatment of Alzheimer's disease. Their findings, based on studies in cell culture, mice and tissue ...

Scientists from DZNE, University Hospital Bonn (UKB) and the University of Bonn provide new evidence that preventing brain inflammation is a promising approach for the treatment of Alzheimer's disease ...

In an extended follow-up study, intensive blood pressure control is associated with reductions in the rate of cognitive impairment.

More about lecanemab More about donanemab When people can be diagnosed in the earlier stages of dementia and access new disease-modifying treatments, the typical pattern of decline experienced by ...